We would love to hear your thoughts about our site and services, please take our survey here.
As a long term holder of the shares but not (yet) a subscriber of yours, I'm dispassionately curious about these posts. If a CEO is giving you "actionable information" to sell, isn't that some sort of insider trading? If it isn't, then it's not worth paying for. Could you give me a steer, please?
Genuine question about the reported results from a long term holder (not selling). Why did so few complete the study? Or to put it another way: why did so many drop out? No efficacy? This has a bearing on the reported % success. They’re clearly great results anyway, for those that it did help; I’m just being cautious here.
“Of participants that enrolled onto the study, 177 identified themselves as suffering from mild to moderate psoriasis. Of these, 142 commenced the study and completed the day 7 questionnaire with 91 reporting for the entire 56 day study period. The study results are calculated on the basis of the feedback from the 91 participants who reported for the entire period.“
Subscribe on the website: the porridge comes in the post. It’s remarkable stuff.
Likewise. I’d had a hunch that the market was undervaluing these and overplaying the impact of the vaccine rollout. The update confirmed it. I’m glad that I had added. I’m not sure why stt1 is so aggressively negative.
It's always been large, in my recollection. Welcome back.
Yep. Double top.
I wonder. Classic double top forming?
I believe it was simply people piling in on momentum without the faintest clue what the company is or does - and who couldn't care less. Someone on here literally said that. Can we all calm down please. (I'm a long-term investor).
Not really: volume is very modest. I'm enjoying the ride, but I suspect a lot of it is froth. We shall see!
Dazed - Link is via Investor Meet: https://www.investormeetcompany.com (free registration).
I see that CBX is about to join the medicinal cannabinoid offering: anyone's thoughts on the relative merits, please?
I expect the latest UK seabed auction hasn't helped. Profiteering by the Crown along with increasing competition from oil companies trying to diversify - all a bit ironic really.
Basel III? https://youtu.be/KdtlEjvRA9o
Given that it happened several months ago and the SP has been on an upwards roll ever since, not much I would have thought. Tens of millions (if that's what it ends up costing) might be a lot to us but it's small beer to SSE. What made you raise the issue now?
Oh wow, I knew wooly was a bit strange but now I can see he's even more unhinged than Trump. Here's a good read old fruit: https://medium.com/curiouserinstitute/a-game-designers-analysis-of-qanon-580972548be5
Wealthy people get wealthier in our sad little system. But why single out Gates (who does a huge amount to benefit humanity and is committed to giving away almost all his money)? How come nobody ever mentions the Arnaults, for example, or the Waltons? I'm curious.
"it would seem the market agrees with me, with the sp being 7% down"
Is that the same sp that's up 25%+ since July?
"But they might give a 25, 50 or even 75% discount, else why should these other companies bother to push it for us?
What's in it for them?"
anon3 I'm in business. I pay full price for my raw materials; I then add a 300% markup to reflect what I bring to the product. Which is good, so people pay it. (Also I never bother with sale offers or "Black Friday" deals). Wait - paying full price for the materials? Am I crazy? What's in it for me?
>> "Can you point me to where it says they're paying for it?"
Sure: "UITC has agreed to place an order for 5,000 boxes ..."
Can you point me to where I can "place an order for 5,000 boxes" (or even one box) *without* paying? Or provide your definition of the phrase "place an order" in a commercial context?
Overpriced obviously. Moan moan moan. Look at the pattern while it marks time, building the business in the background. Trade the waves. When the ask goes below 50, buy some; sell at will. Better than dividends!